Polaris Partners

Delphia Therapeutics, headquartered in Boston, USA, is a biotechnology company focused on cancer therapeutics. It operates a laboratory dedicated to studying cancer-driving pathways and developing treatments that target and over-activate specific cancer-linked cell signaling, ultimately leading to the death of tumor cells.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2016. It specializes in drug discovery, particularly focusing on solute carrier (SLC) transporters, which are vital for understanding various disease pathways. The company’s efforts are directed towards immunometabolism, lysosomal function, and mucosal defense, with applications in immuno-oncology, inflammatory disorders, and neurological diseases. Utilizing its proprietary RAPID platform, Jnana accelerates the identification of therapeutic targets and the development of small molecule therapies. By leveraging advanced chemoproteomics techniques, the company aims to enhance the efficiency of drug discovery and address significant unmet medical needs in patient care.

Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2016. It specializes in drug discovery, particularly focusing on solute carrier (SLC) transporters, which are vital for understanding various disease pathways. The company’s efforts are directed towards immunometabolism, lysosomal function, and mucosal defense, with applications in immuno-oncology, inflammatory disorders, and neurological diseases. Utilizing its proprietary RAPID platform, Jnana accelerates the identification of therapeutic targets and the development of small molecule therapies. By leveraging advanced chemoproteomics techniques, the company aims to enhance the efficiency of drug discovery and address significant unmet medical needs in patient care.

Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.

Drizly is an online alcohol marketplace that provides a wide selection of beer, wine, and spirits, along with related products such as mixers and garnishes. Founded in 2012 and headquartered in Boston, Massachusetts, the company enables consumers of legal drinking age to conveniently order alcoholic beverages through its platform, benefiting from on-demand delivery and shipping options. Drizly partners with retailers across 235 markets, allowing them to enhance their visibility and reach new customers by bringing their inventory online. This collaboration not only helps retailers diversify their business but also provides valuable market insights to drive sales growth.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2016. It specializes in drug discovery, particularly focusing on solute carrier (SLC) transporters, which are vital for understanding various disease pathways. The company’s efforts are directed towards immunometabolism, lysosomal function, and mucosal defense, with applications in immuno-oncology, inflammatory disorders, and neurological diseases. Utilizing its proprietary RAPID platform, Jnana accelerates the identification of therapeutic targets and the development of small molecule therapies. By leveraging advanced chemoproteomics techniques, the company aims to enhance the efficiency of drug discovery and address significant unmet medical needs in patient care.

Drizly is an online alcohol marketplace that provides a wide selection of beer, wine, and spirits, along with related products such as mixers and garnishes. Founded in 2012 and headquartered in Boston, Massachusetts, the company enables consumers of legal drinking age to conveniently order alcoholic beverages through its platform, benefiting from on-demand delivery and shipping options. Drizly partners with retailers across 235 markets, allowing them to enhance their visibility and reach new customers by bringing their inventory online. This collaboration not only helps retailers diversify their business but also provides valuable market insights to drive sales growth.

Boxever Ltd. is a Dublin-based company that specializes in customer intelligence as a service for the travel industry. Founded in 2010, Boxever provides a digital optimization platform that leverages data and artificial intelligence to enhance customer interactions and experiences. Its main offerings include BOXEVER TX, which visualizes the customer journey, and TX-CORE, a traveler experience management solution that helps clients anticipate customer needs. Additionally, the platform features TX-NOW, an offer management tool, and serves as a comprehensive customer data platform (CDP) that integrates information from various online and offline sources. Boxever collaborates with prominent brands such as Emirates and Ryanair, aiming to transform customer engagement through personalized experiences and data-driven decision-making.

Drizly is an online alcohol marketplace that provides a wide selection of beer, wine, and spirits, along with related products such as mixers and garnishes. Founded in 2012 and headquartered in Boston, Massachusetts, the company enables consumers of legal drinking age to conveniently order alcoholic beverages through its platform, benefiting from on-demand delivery and shipping options. Drizly partners with retailers across 235 markets, allowing them to enhance their visibility and reach new customers by bringing their inventory online. This collaboration not only helps retailers diversify their business but also provides valuable market insights to drive sales growth.

Boxever Ltd. is a Dublin-based company that specializes in customer intelligence as a service for the travel industry. Founded in 2010, Boxever provides a digital optimization platform that leverages data and artificial intelligence to enhance customer interactions and experiences. Its main offerings include BOXEVER TX, which visualizes the customer journey, and TX-CORE, a traveler experience management solution that helps clients anticipate customer needs. Additionally, the platform features TX-NOW, an offer management tool, and serves as a comprehensive customer data platform (CDP) that integrates information from various online and offline sources. Boxever collaborates with prominent brands such as Emirates and Ryanair, aiming to transform customer engagement through personalized experiences and data-driven decision-making.

Solace Pharmaceuticals, a Boston based drug company focused on therapeutics for chronic pain.